ASTH Q3 2026 deep dive: margin expansion and Medicaid headwinds shape cautious outlook
Astrana Health (ASTH) Falls After Earnings As The Bull Case Still Points To Value
Astrana Health, Inc. (ASTH) Q3 2026 Earnings Call Transcript
Astrana Health, Inc. Q3 2026 Earnings Call Summary
Astrana Health Inc (ASTH) (Q3 2026) Earnings Call Highlights: Record Revenue and EBITDA Growth ...
Needham Maintains Buy on Astrana Health, Raises Price Target to $45
Astrana Health (ASTH) Q3 2026 Earnings Call Transcript
Astrana Health Q3 Earnings Call Highlights
Astrana Health, Inc. 2026 Q3 - Results - Earnings Call Presentation
Astrana Health (NASDAQ:ASTH) Q3 Revenue In Line, EPS Miss Leaves Shares Flat
Astrana Health (NASDAQ:ASTH) reports Q3 2026 in line with expectations but quarterly revenue guidance misses expectations
Astrana Health, Inc. (ASTH) Q3 Earnings Lag Estimates
Astrana Health, Inc. Reports Third Quarter 2026 Results
Astrana Health Q3 2026 Earnings Call Transcript
Astrana Health Narrows FY2026 Sales Guidance from $3.800B-$4.100B to $3.900B-$4.000B vs $3.980B Est
Astrana Health Sees Q4 Sales $939.000M-$1.039B vs $1.034B Est
Astrana Health Q3 EPS $0.26 Misses $0.45 Estimate, Sales $1.023B Beat $1.020B Estimate
Is Astrana Health (ASTH) Undervalued Following Its Verda Healthcare Partnership?
How Investors May Respond To Astrana Health (ASTH) Expanding Culturally Tailored Care In Underserved U.S. Communities
Astrana Health (ASTH) Stock Could Look Fully Priced On New Multi State Partnership
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.